Orphan receptor
CA 2340475 C · Owner: Enmark, Eva · Inventors: Gustafsson, Jan Ake; Kuiper, George G.J.M.; Enmark, Eva
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to a novel estrogen receptor-related nuclear receptor hereinafter termed "ER.beta." having the amino acid sequence of Figs. 1,13A or 14A or substantially the same amino acid sequence as the amino acid sequence shown in Figs. 1 13A or 13B or an amino acid sequence functionally similar to that sequence. The invention also relates to DNA sequences encoding the receptor. The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and other hormonal effects.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 9, 1996 and granted August 20, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 9, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 9, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.